Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide. Elevated low-denisty lipoprotein-cholesterol (LDL-C) is an established risk factor for ASCVD and primary target of therapy for prevention of major adverse cardiovascular events.
↧